Sustainability aspects in production

Emissions in the upstream and downstream value chain – Scope 3

We need raw materials and pre-products to manufacture our products, such as nutritional supplements, infusion solutions, infusion bags and drugs. The finished products are in turn supplied via distributors to pharmacies, hospitals and health centers and ultimately to patients for use. All these steps generate indirect greenhouse gas emissions, known as Scope 3 emissions.

Human rights

Our commitment to respecting human rights extends beyond our own corporate activities and our core business. For example, we source raw materials and intermediate products for production from other Fresenius Kabi sites as well as from external suppliers. In line with our human rights program, we take human rights concerns into account when selecting and working with our suppliers and business partners.¹

¹Detailed information on the measures of our human rights program can be found in our audited Sustainability Statement 2025.

Product development

The further or new development of products and processes is an integral part of our strategy. Developments take place at various levels. In the area of biosimilars, we are dedicated to the development of cost-effective drugs based on reference products.

Water and wastewater

Water is a valuable resource. To ensure the quality of our products, we depend on the availability of water. That is why we have set ourselves the target of reducing process water. We aim to reduce absolute process water withdrawal at production sites in areas with water stress by 20% by 2030 (base year: 2023; baseline value: 3,518,096 m³).¹ At the same time, we are responsible for the proper handling of wastewater from production.

¹We report in detail on our reduction target, the measures planned to achieve it, and current progress in our audited Sustainability Statement 2025.

Automation and digitalization

Automation and digitalization can support process stability and product quality. In production, for example, sections such as filling, sterilization, and packaging are completely automated.

Energy and climate

High-energy processes are used at our production sites, such as the sterilization of infusion solutions in an autoclave. In order to reduce the greenhouse gas emissions released by these processes as far as possible, we are gradually driving forward energy efficiency measures as well as the use of renewable energy and the expansion of photovoltaic systems. These are levers for our group-wide climate targets.¹

¹Detailed information on our climate targets and our climate transition plan can be found in our audited Sustainability Statement 2025.

Quality of the products

Patient safety and therefore product quality are our top priority. Structured processes, training and comprehensive quality management are fundamental to this. Regular checks are carried out at our sites to ensure that all relevant standards and regulations are complied with.

Resource management

We source various raw materials and intermediates for the manufacture of our healthcare products. Waste is mainly generated as by-products of production processes or as packaging material in the downstream value chain.

Occupational safety and working conditions

We want to offer our employees a safe and healthy working environment. We support them in their personal development with appropriate programs through a culture of learning.

Access to healthcare

It is our task to develop products that help to promote medical progress in acute and follow-up care and improve the quality of life of patients. At the same time, we want our products to enable more and more people around the world to have access to high-quality and modern therapies.

Responsible partnerships

We act in accordance with our Code of Conduct and the Fresenius Principles. We expect our business partners to commit to our ethical principles in accordance with the Business Partner Code of Conduct. At the same time, we promote cooperation with NGOs, public authorities, and other companies to drive innovation and solutions along the value chain.